Literature DB >> 16613852

Transformation by the Rho-specific guanine nucleotide exchange factor Dbs requires ROCK I-mediated phosphorylation of myosin light chain.

Zhuoming Liu1, Elena V Kostenko, Gwendolyn M Mahon, Oyenike O Olabisi, Ian P Whitehead.   

Abstract

Dbs was identified in a cDNA-based expression screen for sequences that can cause malignant growth when expressed in murine fibroblasts. In previous studies we have shown that Dbs is a Rho-specific guanine nucleotide exchange factor that can activate RhoA and/or Cdc42 in a cell-specific manner. In this current study we have used a combination of genetic and pharmacological approaches to examine the relative contributions of RhoA x PRK and RhoA x ROCK signaling to Dbs transformation. Our analysis indicates that ROCK is activated in Dbs-transformed cells and that Dbs transformation is dependent upon ROCK I activity. In contrast, there appears to be no requirement for PRK activation in Dbs transformation. Dbs transformation is also associated with increased phosphorylation of myosin light chain and stress fiber formation, both of which occur in a ROCK-dependent manner. Suppression of myosin light chain expression by small interfering RNAs impairs Dbs focus formation, thus establishing a direct link between actinomyosin contraction and Rho-specific guanine nucleotide exchange factor transformation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16613852     DOI: 10.1074/jbc.M601823200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  Ccpg1, a novel scaffold protein that regulates the activity of the Rho guanine nucleotide exchange factor Dbs.

Authors:  Elena V Kostenko; Oyenike O Olabisi; Sutapa Sahay; Pedro L Rodriguez; Ian P Whitehead
Journal:  Mol Cell Biol       Date:  2006-09-25       Impact factor: 4.272

2.  The rho-specific guanine nucleotide exchange factor Dbs regulates breast cancer cell migration.

Authors:  Zhuoming Liu; Homer C Adams; Ian P Whitehead
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

3.  Identification of fusion genes in breast cancer by paired-end RNA-sequencing.

Authors:  Henrik Edgren; Astrid Murumagi; Sara Kangaspeska; Daniel Nicorici; Vesa Hongisto; Kristine Kleivi; Inga H Rye; Sandra Nyberg; Maija Wolf; Anne-Lise Borresen-Dale; Olli Kallioniemi
Journal:  Genome Biol       Date:  2011-01-19       Impact factor: 13.583

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.